Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
ID: 356193Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356193
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for pilot and exploratory policy research projects focused on health disparities related to tobacco, alcohol, and cannabis use. The initiative seeks to examine new or adapted policies in the U.S. that address these disparities, with the goal of advancing equitable policies in these areas. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application due date anticipated in March 2025. Interested applicants are encouraged to participate in a pre-application webinar and can access additional resources, including a presentation and slides, through the provided links. The estimated award date is December 1, 2025, and there is no cost-sharing or matching requirement for applicants.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
    Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science, inviting R01 research applications that focus on biomedical and behavioral research to inform tobacco product regulation. This initiative aims to generate scientific data that will enhance public health protections related to tobacco use, with a particular emphasis on fostering diverse perspectives through a simplified peer review framework. The total estimated funding for this program is $4 million, with an award ceiling of $500,000 for each of the anticipated five awards, and the NOFO is expected to be published in Winter 2024, with applications due in Summer 2025. Interested applicants should prepare to submit new applications, as only new proposals will be considered, and further details will be available upon the official release of the NOFO.
    Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at accelerating substance use research through the utilization of existing data, specifically under the R21 grant mechanism. This initiative seeks to foster innovative research projects that leverage pre-existing datasets to enhance understanding and treatment of substance use disorders. The total estimated funding for this program is $2 million, with an award ceiling of $200,000 per project and an anticipated three awards to be made. Interested applicants should note that the NOFO is expected to be published in Fall 2024, with applications due in Spring 2025, and the estimated award date is set for April 1, 2026.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." This initiative aims to support pilot and preliminary research that prepares for larger-scale trials focused on improving access to and the effectiveness of treatment services for substance use disorders. The funding is intended to facilitate the testing of various intervention approaches and methodologies, ultimately contributing to the development of effective treatment strategies that address health disparities among vulnerable populations. Applicants may receive up to $450,000 over a three-year period, with proposals due by 5:00 PM local time on January 7, 2025. For further information, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-180.html.
    Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research aimed at improving Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) strategies for alcohol, tobacco, and other drug (ATOD) use among adult populations experiencing health disparities. This initiative seeks innovative approaches to implement SBIRT/P, focusing on addressing the unique barriers faced by these populations, and encourages collaboration with healthcare and community partners to enhance the sustainability of these interventions. The funding opportunity, categorized as R01, is part of NIH's broader goal to increase prevention research targeting leading risk factors for morbidity and mortality, with applications due starting January 5, 2024, and closing on May 7, 2027. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory and developmental research that investigates how structural racism influences substance use trajectories, with a focus on reducing the risk of substance use disorders and informing preventive strategies. The program encourages a multidisciplinary approach, integrating fields such as neuroscience, epidemiology, and sociology, while promoting community-engaged research methods to enhance racial equity. Interested applicants can apply for funding up to $500,000 for the initial R61 phase, with a total anticipated funding of $1.5 million annually for multiple awards. The application deadline is November 14, 2024, and further details can be found at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research," aimed at supporting R01 applications that focus on community-partnered research to mitigate disparities in substance misuse and health outcomes among racial and ethnic minority populations. This initiative emphasizes the establishment of collaborative community partnerships to ensure that research addresses immediate community needs and employs effective methodologies, thereby advancing health equity in the context of substance use and addiction. The program has a budget of approximately $2 million for FY 2023, with applications due by November 14, 2024. Interested applicants can find more information and application instructions at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Tobacco Regulatory Science (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Tobacco Regulatory Science (R01 Clinical Trial Optional)" funding opportunity, aimed at supporting biomedical and behavioral research to inform the regulation of tobacco products and protect public health. This initiative seeks R01 research project grant applications that address key research priorities, including the composition and design of tobacco products, toxicity assessments, addiction studies, and the health effects of tobacco use. A total of up to six R01 grants, with a combined funding of $4 million for fiscal year 2024, will be awarded to eligible applicants, which include a diverse range of institutions and organizations. Interested parties should submit their applications by May 4, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html for further details.
    Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research," aimed at supporting urgent exploratory research in substance use epidemiology and health services. This funding initiative focuses on five priority areas, including responses to sudden spikes in drug use, emerging marijuana trends, and time-sensitive issues related to prescription drug abuse and addiction services within the evolving healthcare system. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and state or local governments, with funding available up to $275,000 over a two-year period. Interested parties should note that the application deadline is January 14, 2025, and are encouraged to consult with NIH contacts for alignment with the FOA’s priorities. For further details, applicants can refer to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.